167 related articles for article (PubMed ID: 22508302)
1. The anthelmintic triclabendazole and its metabolites inhibit the membrane transporter ABCG2/BCRP.
Barrera B; Otero JA; Egido E; Prieto JG; Seelig A; Álvarez AI; Merino G
Antimicrob Agents Chemother; 2012 Jul; 56(7):3535-43. PubMed ID: 22508302
[TBL] [Abstract][Full Text] [Related]
2. Effects of triclabendazole on secretion of danofloxacin and moxidectin into the milk of sheep: role of triclabendazole metabolites as inhibitors of the ruminant ABCG2 transporter.
Barrera B; González-Lobato L; Otero JA; Real R; Prieto JG; Álvarez AI; Merino G
Vet J; 2013 Nov; 198(2):429-36. PubMed ID: 23981352
[TBL] [Abstract][Full Text] [Related]
3. Transport of anthelmintic benzimidazole drugs by breast cancer resistance protein (BCRP/ABCG2).
Merino G; Jonker JW; Wagenaar E; Pulido MM; Molina AJ; Alvarez AI; Schinkel AH
Drug Metab Dispos; 2005 May; 33(5):614-8. PubMed ID: 15703302
[TBL] [Abstract][Full Text] [Related]
4. N-(4-[2-(1,2,3,4-tetrahydro-6,7-dimethoxy-2-isoquinolinyl)ethyl]-phenyl)-9,10-dihydro-5-methoxy-9-oxo-4-acridine carboxamide (GF120918) as a chemical ATP-binding cassette transporter family G member 2 (Abcg2) knockout model to study nitrofurantoin transfer into milk.
Wang L; Leggas M; Goswami M; Empey PE; McNamara PJ
Drug Metab Dispos; 2008 Dec; 36(12):2591-6. PubMed ID: 18799806
[TBL] [Abstract][Full Text] [Related]
5. Relative activity of triclabendazole metabolites against the liver fluke, Fasciola hepatica.
Halferty L; Brennan GP; Trudgett A; Hoey L; Fairweather I
Vet Parasitol; 2009 Feb; 159(2):126-38. PubMed ID: 19027238
[TBL] [Abstract][Full Text] [Related]
6. Secretion into Milk of the Main Metabolites of the Anthelmintic Albendazole Is Mediated by the ABCG2/BCRP Transporter.
Blanco-Paniagua E; Álvarez-Fernández L; Garcia-Lino AM; Álvarez AI; Merino G
Antimicrob Agents Chemother; 2022 Jul; 66(7):e0006222. PubMed ID: 35736132
[TBL] [Abstract][Full Text] [Related]
7. Analysis of the effect of the bovine adenosine triphosphate-binding cassette transporter G2 single nucleotide polymorphism Y581S on transcellular transport of veterinary drugs using new cell culture models.
Real R; González-Lobato L; Baro MF; Valbuena S; de la Fuente A; Prieto JG; Alvarez AI; Marques MM; Merino G
J Anim Sci; 2011 Dec; 89(12):4325-38. PubMed ID: 21821808
[TBL] [Abstract][Full Text] [Related]
8. Assessment of the main metabolism pathways for the flukicidal compound triclabendazole in sheep.
Virkel G; Lifschitz A; Sallovitz J; Pis A; Lanusse C
J Vet Pharmacol Ther; 2006 Jun; 29(3):213-23. PubMed ID: 16669866
[TBL] [Abstract][Full Text] [Related]
9. The breast cancer resistance protein (BCRP/ABCG2) affects pharmacokinetics, hepatobiliary excretion, and milk secretion of the antibiotic nitrofurantoin.
Merino G; Jonker JW; Wagenaar E; van Herwaarden AE; Schinkel AH
Mol Pharmacol; 2005 May; 67(5):1758-64. PubMed ID: 15709111
[TBL] [Abstract][Full Text] [Related]
10. Resistance-induced changes in triclabendazole transport in Fasciola hepatica: ivermectin reversal effect.
Mottier L; Alvarez L; Fairweather I; Lanusse C
J Parasitol; 2006 Dec; 92(6):1355-60. PubMed ID: 17304820
[TBL] [Abstract][Full Text] [Related]
11. In vivo inhibition of BCRP/ABCG2 mediated transport of nitrofurantoin by the isoflavones genistein and daidzein: a comparative study in Bcrp1 (-/-) mice.
Merino G; Perez M; Real R; Egido E; Prieto JG; Alvarez AI
Pharm Res; 2010 Oct; 27(10):2098-105. PubMed ID: 20607366
[TBL] [Abstract][Full Text] [Related]
12. ABCG2 transporter plays a key role in the biodistribution of melatonin and its main metabolites.
Álvarez-Fernández L; Gomez-Gomez A; Haro N; García-Lino AM; Álvarez AI; Pozo OJ; Merino G
J Pineal Res; 2023 Mar; 74(2):e12849. PubMed ID: 36562106
[TBL] [Abstract][Full Text] [Related]
13. Breast cancer resistance protein (BCRP/ABCG2) transports fluoroquinolone antibiotics and affects their oral availability, pharmacokinetics, and milk secretion.
Merino G; Alvarez AI; Pulido MM; Molina AJ; Schinkel AH; Prieto JG
Drug Metab Dispos; 2006 Apr; 34(4):690-5. PubMed ID: 16434544
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of ABCG2/BCRP transporter by soy isoflavones genistein and daidzein: effect on plasma and milk levels of danofloxacin in sheep.
Perez M; Otero JA; Barrera B; Prieto JG; Merino G; Alvarez AI
Vet J; 2013 May; 196(2):203-8. PubMed ID: 23083838
[TBL] [Abstract][Full Text] [Related]
15. In vitro interaction of the pesticides flupyradifurone, bupirimate and its metabolite ethirimol with the ATP-binding cassette transporter G2 (ABCG2).
Ben Halima N; Álvarez-Fernández L; Blanco-Paniagua E; Abid-Essefi S; Guedri Y; Merino G
Toxicol Lett; 2023 May; 380():23-30. PubMed ID: 37011773
[TBL] [Abstract][Full Text] [Related]
16. Mechanism of the pharmacokinetic interaction between methotrexate and benzimidazoles: potential role for breast cancer resistance protein in clinical drug-drug interactions.
Breedveld P; Zelcer N; Pluim D; Sönmezer O; Tibben MM; Beijnen JH; Schinkel AH; van Tellingen O; Borst P; Schellens JH
Cancer Res; 2004 Aug; 64(16):5804-11. PubMed ID: 15313923
[TBL] [Abstract][Full Text] [Related]
17. Abcg2 transporter affects plasma, milk and tissue levels of meloxicam.
Garcia-Lino AM; Blanco-Paniagua E; Astorga-Simon EN; Alvarez-Fernandez L; Garcia-Mateos D; Alvarez-Fernandez I; Alvarez AI; Merino G
Biochem Pharmacol; 2020 May; 175():113924. PubMed ID: 32217099
[TBL] [Abstract][Full Text] [Related]
18. Natural allelic variants of bovine ATP-binding cassette transporter ABCG2: increased activity of the Ser581 variant and development of tools for the discovery of new ABCG2 inhibitors.
Merino G; Real R; Baro MF; Gonzalez-Lobato L; Prieto JG; Alvarez AI; Marques MM
Drug Metab Dispos; 2009 Jan; 37(1):5-9. PubMed ID: 18824523
[TBL] [Abstract][Full Text] [Related]
19. The gut microbiota ellagic acid-derived metabolite urolithin A and its sulfate conjugate are substrates for the drug efflux transporter breast cancer resistance protein (ABCG2/BCRP).
González-Sarrías A; Miguel V; Merino G; Lucas R; Morales JC; Tomás-Barberán F; Alvarez AI; Espín JC
J Agric Food Chem; 2013 May; 61(18):4352-9. PubMed ID: 23586460
[TBL] [Abstract][Full Text] [Related]
20. Altered drug influx/efflux and enhanced metabolic activity in triclabendazole-resistant liver flukes.
Alvarez LI; Solana HD; Mottier ML; Virkel GL; Fairweather I; Lanusse CE
Parasitology; 2005 Oct; 131(Pt 4):501-10. PubMed ID: 16174415
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
